{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:22:48Z","timestamp":1787764968570,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rheumatic heart disease\/Rheumatic fever is a non \u2013 communicable disease being a major neglected health problem. Recurrent attacks of rheumatic fever can have catastrophic outcomes, therefore regular administration of antibiotics is recommended. During COVID 19 pandemic, people were afraid to approach hospitals hence the compliance and follow up of patients were affected. This study had planned to assess the treatment adherence of patients diagnosed with rheumatic fever\/rheumatic heart disease during COVID 19 pandemic and to describe the socio demographic factors, clinical characteristics. This study also determines the factors associated with the treatment adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A cross sectional study was conducted among Rheumatic Fever\/Rheumatic Heart Disease patients, attending Outpatient department at tertiary care hospital during COVID 19 pandemic. Mean score with confidence interval was calculated for quantitative data.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value less than 0.05 is significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The Mean (SD) age of the study participants was 41 \u00b1 14.17 years. Treatment adherence was found to be 94.5 percent among Rheumatic Fever\/Rheumatic Heart Disease patients during COVID 19 pandemic. 89.5% of injection benzathine penicillin users had an adherence rate above 80 percent. It was found that the presence of comorbidities (Diabetes\/Hypertension\/both Diabetes and Hypertension) had a statistically significant association with treatment adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Rheumatic Heart Disease is a disease of young and middle -age population affecting predominantly females. The overall adherence rate among Rheumatic Fever\/Rheumatic Heart Disease patients was high. High time to maintain hospital-based registry to have follow up of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_941_23","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T16:00:58Z","timestamp":1702915258000},"page":"3254-3261","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Treatment adherence and its determinants among the rheumatic fever\/rheumatic heart disease patients during COVID 19 pandemic \u2013 A cross sectional study from Chandigarh, India"],"prefix":"10.4103","volume":"12","author":[{"given":"Divya","family":"Ilanchoorian","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Vijayvergiya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur K.","family":"Jindal","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Sanath Nagar, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sagar","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"R1-20260511","article-title":"Jai Vigyan Mission Mode Project Community Control of Rheumatic Fever\/Rheumatic Heart Disease in India","year":"2010"},{"issue":"Suppl 1","key":"R2-20260511","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s12098-012-0853-2","article-title":"Rheumatic heart disease: Progress and challenges in India","volume":"80","author":"Shah","year":"2013","journal-title":"Indian J Pediatr"},{"key":"R3-20260511","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12098-019-03128-7","article-title":"Rheumatic Fever and Rheumatic Heart Disease in Children","volume":"87","author":"Arvind","year":"2020","journal-title":"Indian J Pediatr"},{"key":"R4-20260511","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ahj.2012.01.003","article-title":"Rationale and design of a global rheumatic heart disease registry: The REMEDY study","volume":"163","author":"Karthikeyan","year":"2012","journal-title":"Am Heart J"},{"key":"R5-20260511","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: Implications for closing the gap: A scientific statement from the American Heart Association","volume":"142","author":"Kumar","year":"2020","journal-title":"Circulation"},{"key":"R6-20260511","article-title":"SEVENTY-FIRST WORLD HEALTH ASSEMBLY A71\/25 Provisional agenda item 12.8 Rheumatic fever and rheumatic heart disease Report by the Director-General","year":"2018"},{"key":"R7-20260511","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ijcard.2016.08.259","article-title":"Characteristics and outcomes of Indian children enrolled in a rheumatic heart disease registry","volume":"222","author":"Mehta","year":"2016","journal-title":"Int J Cardiol"},{"key":"R8-20260511","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","article-title":"Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: Two-Year follow-up of the global rheumatic heart disease registry (the REMEDY Study)","volume":"134","author":"Z\u00fchlke","year":"2016","journal-title":"Circulation"},{"key":"R9-20260511","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jpc.15239","article-title":"Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever","volume":"57","author":"Kevat","year":"2021","journal-title":"J Paediatr Child Health"},{"key":"R10-20260511","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1179\/2047773214Y.0000000146","article-title":"Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica","volume":"108","author":"Thompson","year":"2014","journal-title":"Pathog Glob Health"},{"key":"R11-20260511","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4103\/jfmpc.jfmpc_1056_19","article-title":"Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: A cross-sectional study in low-income province of India","volume":"9","author":"Prasad","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"R12-20260511","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ihj.2018.12.007","article-title":"Current status of rheumatic heart disease in India","volume":"71","author":"Negi","year":"2019","journal-title":"Indian Heart J"},{"key":"R13-20260511","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijmr.IJMR_504_20","article-title":"Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach","volume":"151","author":"Mandal","year":"2020","journal-title":"Indian J Med Res"},{"key":"R14-20260511","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3329\/cardio.v10i2.36289","article-title":"Factors affecting therapeutic compliance among the patients with rheumatic heart disease in Bangladesh","volume":"10","author":"Farzana","year":"2018","journal-title":"Cardiovasc J"},{"key":"R15-20260511","first-page":"282","article-title":"Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India","volume":"49","author":"Kumar","year":"1997","journal-title":"Indian Heart J"},{"key":"R16-20260511","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/PPA.S238423","article-title":"Adherence to benzathine penicillin g secondary prophylaxis and its determinants in patients with rheumatic heart disease at a cardiac center of an Ethiopian tertiary care teaching hospital","volume":"14","author":"Mekonen","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"R17-20260511","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5830\/CVJA-2013-022","article-title":"Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital","volume":"24","author":"Musoke","year":"2013","journal-title":"Cardiovasc J Afr"},{"key":"R18-20260511","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5694\/j.1326-5377.2006.tb00347.x","article-title":"Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community","volume":"184","author":"Harrington","year":"2006","journal-title":"Med J Aust"},{"key":"R19-20260511","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1440-1584.2007.00896.x","article-title":"Acute rheumatic fever: Adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory","volume":"15","author":"Stewart","year":"2007","journal-title":"Aust J Rural Health"},{"key":"R20-20260511","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/trstmh\/trx035","article-title":"Secondary prevention for screening detected rheumatic heart disease: Opportunities to improve adherence","volume":"111","author":"Engelman","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R21-20260511","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.gheart.2018.06.001","article-title":"Clinical characteristics, complications, and treatment practices in patients with RHD: 6-Year results from HP-RHD Registry","volume":"13","author":"Negi","year":"2018","journal-title":"Glob Heart"},{"key":"R22-20260511","doi-asserted-by":"crossref","first-page":"e0006577","DOI":"10.1371\/journal.pntd.0006577","article-title":"The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review","volume":"12","author":"Coffey","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"R23-20260511","first-page":"70","article-title":"Streptococcal pharyngitis, rheumatic fever and rheumatic heart disease: Eight-year prospective surveillance in Rupnagar district of Punjab, India","volume":"27","author":"Kumar","year":"2014","journal-title":"Natl Med J India"},{"key":"R24-20260511","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehu449","article-title":"Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The global rheumatic heart disease registry (the REMEDY study)","volume":"36","author":"Z\u00fchlke","year":"2015","journal-title":"Eur Heart J"},{"key":"R25-20260511","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.acvd.2015.12.004","article-title":"The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa","volume":"109","author":"Kingu\u00e9","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"R26-20260511","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 3(Suppl 3)","key":"R27-20260511","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ihj.2018.05.013","article-title":"Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever\/Rheumatic Heart Disease (HP-RF\/RHD) Registry","volume":"70","author":"Negi","year":"2018","journal-title":"Indian Heart J"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_941_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:54:04Z","timestamp":1787763244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_941_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_941_23","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2023-06-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}